Clinical Trial Update: A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose vitamin C (ascorbate) for pancreatic cancer has completed (PACMAN 2.1).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Vitamin C (ascorbic acid) (ascorbic acid)

Snippet

Sponsor: Joseph J. Cullen | Conditions: Pancreatic Neoplasms, Cancer of Pancreas | Phase 2 | Status: COMPLETED